Suppr超能文献

药效学原理及其在兽医药理学中的应用。

Principles of pharmacodynamics and their applications in veterinary pharmacology.

作者信息

Lees P, Cunningham F M, Elliott J

机构信息

Department of Veterinary Basic Sciences, Royal Veterinary College, Hawkshead Campus, Hatfield, Hertfordshire AL9 7TA, UK.

出版信息

J Vet Pharmacol Ther. 2004 Dec;27(6):397-414. doi: 10.1111/j.1365-2885.2004.00620.x.

Abstract

Pharmacodynamics (PDs) is the science of drug action on the body or on microorganisms and other parasites within or on the body. It may be studied at many organizational levels--sub-molecular, molecular, cellular, tissue/organ and whole body--using in vivo, ex vivo and in vitro methods and utilizing a wide range of techniques. A few drugs owe their PD properties to some physico-chemical property or action and, in such cases, detailed molecular drug structure plays little or no role in the response elicited. For the great majority of drugs, however, action on the body is crucially dependent on chemical structure, so that a very small change, e.g. substitution of a proton by a methyl group, can markedly alter the potency of the drug, even to the point of loss of activity. In the late 19th century and first half of the 20th century recognition of these facts by Langley, Ehrlich, Dale, Clarke and others provided the foundation for the receptor site hypothesis of drug action. According to these early ideas the drug, in order to elicit its effect, had to first combine with a specific 'target molecule' on either the cell surface or an intracellular organelle. It was soon realized that the 'right' chemical structure was required for drug-target site interaction (and the subsequent pharmacological response). In addition, from this requirement, for specificity of chemical structure requirement, developed not only the modern science of pharmacology but also that of toxicology. In relation to drug actions on microbes and parasites, for example, the early work of Ehrlich led to the introduction of molecules selectively toxic for them and relatively safe for the animal host. In the whole animal drugs may act on many target molecules in many tissues. These actions may lead to primary responses which, in turn, may induce secondary responses, that may either enhance or diminish the primary response. Therefore, it is common to investigate drug pharmacodynamics (PDs) in the first instance at molecular, cellular and tissue levels in vitro, so that the primary effects can be better understood without interference from the complexities involved in whole animal studies. When a drug, hormone or neurotransmitter combines with a target molecule, it is described as a ligand. Ligands are classified into two groups, agonists (which initiate a chain of reactions leading, usually via the release or formation of secondary messengers, to the response) and antagonists (which fail to initiate the transduction pathways but nevertheless compete with agonists for occupancy of receptor sites and thereby inhibit their actions). The parameters which characterize drug receptor interaction are affinity, efficacy, potency and sensitivity, each of which can be elucidated quantitatively for a particular drug acting on a particular receptor in a particular tissue. The most fundamental objective of PDs is to use the derived numerical values for these parameters to classify and sub-classify receptors and to compare and classify drugs on the basis of their affinity, efficacy, potency and sensitivity. This review introduces and summarizes the principles of PDs and illustrates them with examples drawn from both basic and veterinary pharmacology. Drugs acting on adrenoceptors and cardiovascular, non-steroidal anti-inflammatory and antimicrobial drugs are considered briefly to provide a foundation for subsequent reviews in this issue which deal with pharmacokinetic (PK)-PD modelling and integration of these drug classes. Drug action on receptors has many features in common with enzyme kinetics and gas adsorption onto surfaces, as defined by Michaelis-Menten and Langmuir absorption equations, respectively. These and other derived equations are outlined in this review. There is, however, no single theory which adequately explains all aspects of drug-receptor interaction. The early 'occupation' and 'rate' theories each explain some, but not all, experimental observations. From these basic theories the operational model and the two-state theory have been developed. For a discussion of more advanced theories see Kenakin (1997).

摘要

药效学是研究药物对机体或机体内外微生物及其他寄生物作用的科学。它可以在许多组织水平上进行研究——亚分子、分子、细胞、组织/器官和整体水平——采用体内、离体和体外方法,并运用多种技术。少数药物的药效学特性归因于某些物理化学性质或作用,在这种情况下,详细的分子药物结构在引发的反应中作用很小或不起作用。然而,对于绝大多数药物来说,对机体的作用关键取决于化学结构,因此,非常小的变化,例如用甲基取代质子,都可能显著改变药物的效力,甚至导致活性丧失。在19世纪末和20世纪上半叶,兰利、埃利希、戴尔、克拉克等人对这些事实的认识为药物作用的受体位点假说奠定了基础。根据这些早期观点,药物为了引发其效应,必须首先与细胞表面或细胞内细胞器上的特定“靶分子”结合。人们很快意识到,药物与靶位点的相互作用(以及随后的药理反应)需要“正确”的化学结构。此外,基于对化学结构特异性的这一要求,不仅发展了现代药理学,还发展了毒理学。例如,关于药物对微生物和寄生虫的作用,埃利希的早期工作导致了对它们具有选择性毒性且对动物宿主相对安全的分子的引入。在整个动物体内,药物可能作用于许多组织中的许多靶分子。这些作用可能导致初级反应,而初级反应又可能诱导次级反应,次级反应可能增强或减弱初级反应。因此,通常首先在体外分子、细胞和组织水平上研究药物药效学,以便在不受整体动物研究中所涉及的复杂性干扰的情况下更好地理解初级效应。当药物、激素或神经递质与靶分子结合时,它被称为配体。配体分为两类,激动剂(通常通过二级信使的释放或形成引发一系列反应从而导致反应)和拮抗剂(不能启动转导途径,但仍与激动剂竞争占据受体位点从而抑制其作用)。表征药物受体相互作用的参数是亲和力、效能、效力和敏感性,对于作用于特定组织中特定受体的特定药物,每一个参数都可以进行定量阐释。药效学最基本的目标是利用这些参数的导出数值对受体进行分类和再分类,并根据药物的亲和力、效能、效力和敏感性对药物进行比较和分类。本综述介绍并总结了药效学原理,并用基础药理学和兽医药理学中的实例进行说明。简要讨论了作用于肾上腺素能受体的药物以及心血管、非甾体抗炎和抗菌药物,为本期后续涉及这些药物类别的药代动力学(PK)-药效学建模及整合的综述提供基础。药物对受体的作用与酶动力学以及气体在表面的吸附有许多共同特征,分别由米氏方程和朗缪尔吸附方程定义。本综述概述了这些及其他导出方程。然而,没有单一的理论能够充分解释药物-受体相互作用的所有方面。早期的“占领”和“速率”理论各自解释了一些但不是所有的实验观察结果。基于这些基础理论,发展出了操作模型和双态理论。关于更高级理论的讨论见凯纳金(1997年)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验